Two weeks after TeNT administration, following the establishment of epilepsy, animals were randomized into two groups and injected via a preimplanted cannula with either the Lenti-CMV-KCNA1 vector or a Lenti-CMV-GFP control vector expressing only GFP. The gene discussed is KCNA1; the disease is epilepsy.